BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 23416081)

  • 1. A miR-151 binding site polymorphism in the 3'-untranslated region of the cyclin E1 gene associated with nasopharyngeal carcinoma.
    Liu Y; Cai H; Liu J; Fan H; Wang Z; Wang Q; Shao M; Sun X; Diao J; Liu Y; Shi Y; Fan Q
    Biochem Biophys Res Commun; 2013 Mar; 432(4):660-5. PubMed ID: 23416081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms in lipid metabolism related miRNA binding sites and risk of metabolic syndrome.
    Ye Q; Zhao X; Xu K; Li Q; Cheng J; Gao Y; Du J; Shi H; Zhou L
    Gene; 2013 Oct; 528(2):132-8. PubMed ID: 23911300
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G-A variant in miR-200c binding site of EFNA1 alters susceptibility to gastric cancer.
    Li Y; Nie Y; Cao J; Tu S; Lin Y; Du Y; Li Y
    Mol Carcinog; 2014 Mar; 53(3):219-29. PubMed ID: 23065816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 3'UTR polymorphism marks differential KLRG1 mRNA levels through disruption of a miR-584-5p binding site and associates with pemphigus foliaceus susceptibility.
    Cipolla GA; Park JK; de Oliveira LA; Lobo-Alves SC; de Almeida RC; Farias TD; Lemos Dde S; Malheiros D; Lavker RM; Petzl-Erler ML
    Biochim Biophys Acta; 2016 Oct; 1859(10):1306-13. PubMed ID: 27424220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A single nucleotide polymorphism in microRNA-146a is associated with the risk for nasopharyngeal carcinoma.
    Lung RW; Wang X; Tong JH; Chau SL; Lau KM; Cheng SH; Woo JK; Woo J; Leung PC; Ng MH; Tang NL; To KF
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E28-38. PubMed ID: 22711332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association between let-7 binding site polymorphism rs712 and risk of nasopharyngeal carcinoma.
    Pan XM; Jia J; Guo XM; Li ZH; Zhang Z; Qin HJ; Xu GH; Gao LB
    Fam Cancer; 2014 Mar; 13(1):93-7. PubMed ID: 23996697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-124-3p inhibits the growth and metastasis of nasopharyngeal carcinoma cells by targeting STAT3.
    Xu S; Zhao N; Hui L; Song M; Miao ZW; Jiang XJ
    Oncol Rep; 2016 Mar; 35(3):1385-94. PubMed ID: 26707908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis.
    Wang K; Li J; Guo H; Xu X; Xiong G; Guan X; Liu B; Li J; Chen X; Yang K; Bai Y
    Carcinogenesis; 2012 Nov; 33(11):2147-54. PubMed ID: 22859270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer.
    Bagheri F; Mesrian Tanha H; Mojtabavi Naeini M; Ghaedi K; Azadeh M
    Mol Med Rep; 2016 May; 13(5):4494-8. PubMed ID: 27035115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between CCNE1 polymorphisms and the risk of breast cancer in a sample of southeast Iranian population.
    Amininia S; Hashemi M; Ebrahimi M; Mashhadi MA; Hashemi SM; Taheri M; Ghavami S
    Med Oncol; 2014 Oct; 31(10):189. PubMed ID: 25159285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rs884225 polymorphism is associated with primary hypertension by compromising interaction between epithelial growth factor receptor (EGFR) and miR-214.
    Luo F; Wu Y; Ding Q; Yuan Y; Jia W
    J Cell Mol Med; 2021 Apr; 25(8):3714-3723. PubMed ID: 33635564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-152 Targets Phosphatase and Tensin Homolog to Inhibit Apoptosis and Promote Cell Migration of Nasopharyngeal Carcinoma Cells.
    Huang S; Li X; Zhu H
    Med Sci Monit; 2016 Nov; 22():4330-4337. PubMed ID: 27840403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3'UTR and 5'UTR of Jab1/CSN5.
    Wang S; Pan Y; Zhang R; Xu T; Wu W; Zhang R; Wang C; Huang H; Calin CA; Yang H; Claret FX
    Oncogene; 2016 Nov; 35(47):6096-6108. PubMed ID: 27157611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in an miRNA-1827 binding site in MYCL1 alters susceptibility to small-cell lung cancer.
    Xiong F; Wu C; Chang J; Yu D; Xu B; Yuan P; Zhai K; Xu J; Tan W; Lin D
    Cancer Res; 2011 Aug; 71(15):5175-81. PubMed ID: 21676885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic polymorphism at miR-181a binding site contributes to gastric cancer susceptibility.
    Lin Y; Nie Y; Zhao J; Chen X; Ye M; Li Y; Du Y; Cao J; Shen B; Li Y
    Carcinogenesis; 2012 Dec; 33(12):2377-83. PubMed ID: 22971574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
    Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
    Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymorphisms in host immune response associated genes and risk of nasopharyngeal carcinoma development in Portugal.
    Sousa H; Mesquita L; Ribeiro J; Catarino R; Breda E; Medeiros R
    Immunobiology; 2016 Feb; 221(2):145-52. PubMed ID: 26391153
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of osteopontin polymorphisms with nasopharyngeal carcinoma risk.
    Wang J; Nong L; Wei Y; Qin S; Zhou Y; Tang Y
    Hum Immunol; 2014 Jan; 75(1):76-80. PubMed ID: 24120738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphism in mature microRNA-608 sequence is associated with an increased risk of nasopharyngeal carcinoma.
    Qiu F; Yang L; Zhang L; Yang X; Yang R; Fang W; Wu D; Chen J; Xie C; Huang D; Zhou Y; Lu J
    Gene; 2015 Jul; 565(2):180-6. PubMed ID: 25861865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human ATF1 rs11169571 polymorphism associated with risk of nasopharyngeal carcinoma in Southern Chinese populations.
    Peng S; Huang GL; Xu N; Lu Y; Zeng L; Li X; Luo S; Lyu X; Jiang Q; Li T; He Z
    Cancer Med; 2019 Apr; 8(4):1893-1898. PubMed ID: 30905073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.